Immunocore Highlights IMCgp100 clinical data in Uveal Melanoma at ASCO 2017 Annual Meeting
Jun 01, 2017 11:26 am UTC| Business
PRESS RELEASE Immunocore Highlights IMCgp100 clinical data in Uveal Melanoma at ASCO 2017 Annual Meeting (Oxford, UK and Conshohocken, US, 1 June 2017) Immunocore Limited, the world's leading TCR company...
Immunocore Highlights IMCgp100 clinical data in Uveal Melanoma at ASCO 2017 Annual Meeting
Jun 01, 2017 11:26 am UTC| Business
PRESS RELEASE Immunocore Highlights IMCgp100 clinical data in Uveal Melanoma at ASCO 2017 Annual Meeting (Oxford, UK and Conshohocken, US, 1 June 2017) Immunocore Limited, the world's leading TCR company...
Immunocore Highlights IMCgp100 clinical data in Uveal Melanoma at ASCO 2017 Annual Meeting
Jun 01, 2017 11:26 am UTC| Business
PRESS RELEASE Immunocore Highlights IMCgp100 clinical data in Uveal Melanoma at ASCO 2017 Annual Meeting (Oxford, UK and Conshohocken, US, 1 June 2017) Immunocore Limited, the world's leading TCR company...
Immunocore Highlights IMCgp100 clinical data in Uveal Melanoma at ASCO 2017 Annual Meeting
Jun 01, 2017 11:26 am UTC| Business
PRESS RELEASE Immunocore Highlights IMCgp100 clinical data in Uveal Melanoma at ASCO 2017 Annual Meeting (Oxford, UK and Conshohocken, US, 1 June 2017) Immunocore Limited, the world's leading TCR company...
Immunocore Highlights IMCgp100 clinical data in Uveal Melanoma at ASCO 2017 Annual Meeting
Jun 01, 2017 11:26 am UTC| Business
PRESS RELEASE Immunocore Highlights IMCgp100 clinical data in Uveal Melanoma at ASCO 2017 Annual Meeting (Oxford, UK and Conshohocken, US, 1 June 2017) Immunocore Limited, the world's leading TCR company...
uniQure Announces Company Presentation at Jefferies Healthcare Conference
Jun 01, 2017 11:24 am UTC| Business
LEXINGTON, Mass. and AMSTERDAM, the Netherlands, June 01, 2017 -- uniQure N.V. (NASDAQ:QURE), a leading gene therapy company advancing transformative therapies for patients with severe medical needs, today announced...
uniQure Announces Company Presentation at Jefferies Healthcare Conference
Jun 01, 2017 11:24 am UTC| Business
LEXINGTON, Mass. and AMSTERDAM, the Netherlands, June 01, 2017 -- uniQure N.V. (NASDAQ:QURE), a leading gene therapy company advancing transformative therapies for patients with severe medical needs, today announced...
Australia’s Corporate Regulator Urges Pension Funds to Boost Technology Investment as Industry Grows